Verastem Inc logo

Verastem Inc

LTS:0LOV (USA)  
$ 5.40 (+17.9%) Nov 29
At Loss
P/B:
19.42
Market Cap:
$ 237.66M
Enterprise V:
$ 187.08M
Volume:
1.97K
Avg Vol (2M):
5.48K
Trade In:
Volume:
1.97K
At Loss
Avg Vol (2M):
5.48K

Business Description

Description
Verastem Inc is late-stage development biopharmaceutical company, committed to advancing new medicines for patients battling cancer. Its pipeline is focused on novel anticancer agents that inhibit critical signaling pathways in cancer that promote cancer cell survival and tumor growth, particularly RAF/MEK inhibition and FAK inhibition.
Name Current Vs Industry Vs History
Cash-To-Debt 2.73
Equity-to-Asset 0.26
Debt-to-Equity 1.29
Debt-to-EBITDA -0.47
Piotroski F-Score 3/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score -9.81
Distress
Grey
Safe
WACC vs ROIC
WACC
ROIC
Name Current Vs Industry Vs History
5-Day RSI 92.81
9-Day RSI 83.55
14-Day RSI 77.13
6-1 Month Momentum % -11.15
12-1 Month Momentum % -46.21

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 3.23
Quick Ratio 3.23
Cash Ratio 3.03
Days Sales Outstanding 126.85

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -21.2
Shareholder Yield % -1.33

Profitability Rank

Name Current Vs Industry Vs History
Operating Margin % -1145.05
Net Margin % -934.54
FCF Margin % -1093.81
ROE % -166.79
ROA % -68.56
ROIC % -856.34
ROC (Joel Greenblatt) % -8626.12
ROCE % -82.81

Financials (Next Earnings Date:2025-03-14 Est.)

LTS:0LOV's 30-Y Financials
Income Statement Breakdown FY
No Enough Data
Balance Sheet Breakdown
No Enough Data
Cashflow Statement Breakdown
No Enough Data

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
No Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015

Verastem Inc Executives

Details

GF Value

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $) 10
EPS (TTM) ($) -3.2
Beta -1.39
Volatility % 107.35
14-Day RSI 77.13
14-Day ATR ($) 0.249477
20-Day SMA ($) 4.109821
12-1 Month Momentum % -46.21
52-Week Range ($) 2.13874 - 13.9409
Shares Outstanding (Mil) 44.51

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 3
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Verastem Inc Filings

Filing Date Document Date Form
No Filing Data

Verastem Inc Stock Events

Financials Calendars
Event Date Price($)
No Event Data

Verastem Inc Frequently Asked Questions

What is Verastem Inc(LTS:0LOV)'s stock price today?
The current price of LTS:0LOV is $5.40. The 52 week high of LTS:0LOV is $13.94 and 52 week low is $2.14.
When is next earnings date of Verastem Inc(LTS:0LOV)?
The next earnings date of Verastem Inc(LTS:0LOV) is 2025-03-14 Est..
Does Verastem Inc(LTS:0LOV) pay dividends? If so, how much?
Verastem Inc(LTS:0LOV) does not pay dividend.

Press Release

Subject Date
No Press Release